:SEER

Guilan Wu1, Jiana Chen1, Peiguang Niu1

  • 1Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, China.

Heliyon
|September 12, 2024
PubMed
概括

这项研究开发了一种新模型,用于预测IV期卵巢癌患者的整体存活率 (OS). 该工具帮助临床医生评估预后,并提供风险分类系统.